CCL17 and asthma: Increased serum levels of the chemokine CCL26/eotaxin-3 could differentiate moderate-to-severe asthma from healthy controls [67], and recent findings point out the ability of CCL17/TARC to predict type-2 eosinophilic asthma [68].